Showing posts from November, 2021

Metals | Spot Prices as of the Close of Trading in New York on Tuesday, November 30, 2021.

 Source: CMI Gold & Silver Spot Prices as of close of trading in New York Tuesday, November 30, 2021 GOLD

Europe and U. S. Market Closing on Tuesday, November 30, 2021:

Image European shares close lower as hawkish Powell comments, omicron fears weigh Elliot Smith, Holly Ellyatt 4 minutes LONDON — European stocks closed lower on Tuesday as new comments from U.S. Federal Reserve Chairman Jerome Powell and fears around the omicron Covid variant weighed on investor sentiment. The pan-European Stoxx 600 closed 0.9% lower, with travel and leisure stocks shedding 2.8% to lead the losses as most sectors and major bourses slid into negative territory. Losses accelerated later in the day after the U.S. Fed ch

India's Economic News: India Economic Recovery in Q2 Analysis.

 Source: Ankit Saproo 5-7 minutes Synopsis The bounce back in the second quarter is led by improvement in private consumption and investment. Private consumption forms the majority of India's overall GDP and is key to a robust climb back from the depths of recession last year. India's Q2 GDP growth rate: Economy grows at 8.4% as disruptions ease after COVID 2nd wave India's GDP grows 8.4% in the second quarter of current fiscal as economic activity gradually inched towards normalcy after second virus wave

Biggest Moves Premarket Analysis on Tuesday, November 30, 2021: Regeneron, Moderna, Dollar tree & More. Hannah Miao 3-4 minutes Check out the companies making headlines in premarket trading. Regeneron Pharmaceuticals (REGN) — Regeneron shares fell more than 1% in the premarket after the company said its C ovid-19 antibody cocktail and similar drugs could be less effective against the omicron Covid variant. The drugmaker said mutations in the variant suggest "there may be reduced neutralization activity of both vaccine-induced and monoclonal antibody conveyed immunity." Moderna (MRNA), Pfizer (PFE) — Shares of vaccine makers were on watch after Moderna CEO Stephane Bancel told the Financial Times he  expects existing vaccines to be less effective  against the omicron variant. Oxford University said there is no evidence yet that current vaccines will not protect against severe disease from omicron. Researchers are still studying the new variant and its ability to evade prior immunity. Moderna shares fell

Cryptocurrency Price Analysis on Tuesday, November 30, 2021 (Morning Report): Ethereum, Litecoin, and Ripple XRP

 Source: Bob Mason 5-7 minutes Ethereum rose by 3.51% on Monday. Following a 4.88% rally on Sunday, Ethereum ended the day at $4,449. A mixed morning saw Ethereum fall to a late morning intraday low $4,282 before making a move. Steering clear of the first major support level at $4,064, Ethereum rallied to a late afternoon intraday high $4,466. Ethereum broke through the first major resistance level at $4,418 to end the day at $4,449 levels. At the time of writing, Ethereum was down by 0.02% to $4,449. A mixed start to the day saw Ethereum rise to an early morning high $4,452 before falling to a low $4,439. Ethereum left the major support and resistance levels untested early on. For the day ahead Ethereum would need to avoid the $4,399 pivot to bring the first major resistance level at $4,516 into play. Support from the broader market would be needed, however, for Ethereum to break back through to $4,500 l

U. S. Market Futures Indication on Tuesday, November 30, 2021: Dow futures are down more than 300 points as investors try to gauge the economic impact of omicron

 Source: Maggie Fitzgerald, Yun Li 4-5 minutes Stock futures tumbled in early Tuesday trading, reversing a Monday rebound on Wall Street as investors reassessed risks associated with the new omicron Covid variant. Futures on the Dow Jones Industrial Average dropped 310 points, or 0.9%. S&P 500 futures tumbled 0.75% and Nasdaq 100 futures shed 0.4%. The reversal came after Moderna CEO Stephane Bancel told the Financial Times that he expects existing vaccines to be less effective against the new variant. The CEO told the paper there could be a "material drop" in the current vaccines' effectiveness against this variant. Bancel told CNBC on Monday that it could take months to develop and ship an omicron-specific vaccine . Separately, Regeneron said its antibody treatment may have reduced effectiveness against omicron. Regeneron shares lost 3% in premarket trading. The 10-year Treasury yield fell

Oil Price Analysis on Tuesday, November 30, 2021(Morning Report): Oil slumps on jitters over vaccine efficacy.

 Source: 3-4 minutes Oil prices tumbled more than 3% on Tuesday after Moderna's CEO cast doubt on the efficacy of Covid-19 vaccines against the Omicron coronavirus variant, spooking financial markets. The head of drugmaker Moderna told the Financial Times that Covid-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been against the Delta variant. Brent crude futures fell $1.97, or 2.7%, to $71.47 per barrel after slipping to an intraday low of $70.52, the lowest since Sept. 1. U.S. West Texas Intermediate (WTI) crude futures fell $1.65, or 2.4%, to $68.30 a barrel, off a session low of $67.06, the weakest since Aug. 26. The Moderna CEO's comments were just a catalyst for the market which was already weak, said a Singapore oil trader who declined to be named due to company policy. Oil plunged around 12% on Friday along with other markets on fears the heavily mutated Omicron

Gold Price Analysis on Tuesday, November 30, 2021 (Morning Report): Gold gains on Moderna CEOs Omicron warning.

 Source: 2-3 minutes Pure 1,000-gram gold bars produced by South Korea's LS-Nikko are stacked in a dealers room in Seoul on January 9, 2009. KIM JAE-HWAN | AFP | Getty Images Gold prices rose on Tuesday after Moderna's chief warned that Covid-19 vaccines are unlikely to be as effective against the Omicron variant as they have been against the Delta version. Spot gold rose 0.3% to $1,790.92 per ounce by 0728 GMT. U.S. gold futures increased 0.4% to $1,792.90. The Moderna chief's comments rattled financial markets, with Asian shares dropping to their lowest in more than a month while crude oil futures fell over 2%. "It is hard to say how much of an impact this will ultimately have on gold as markets are still digesting the comments," CMC Markets UK's chief market analyst Michael Hewson said, adding bullion prices could head back to the $1,800 level if equity markets decline further. Investors will pay close at